A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

A study highlighted the accuracy of three leading continuous glucose monitors (CGM), including systems from Abbott and Dexcom.

A new awareness campaign from Abbott highlights a major sticking point in diabetes management: the harmful impact of societal ...

The FreeStyle Libre 3 system consists of the sensor around the size ... which gives an indication of how well glucose in being controlled over time. Abbott has made the development of wearables ...

Libre Drives Diabetes Care: Abbott’s Diabetes Care business continued to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.

Abbott’s Diabetes Care business continued to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre. In a relatively short span ...

Sinocare announced recently that it successfully defended itself in court against trademark infringement claims brought by ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...